{"nct_id":"NCT01220128","title":"Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer","status":"TERMINATED","status_verified_date":"2021-04","start_date":"2011-04-11","start_date_type":"ACTUAL","primary_completion_date":"2014-11-14","primary_completion_date_type":"ACTUAL","completion_date":"2014-11-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}